Drug-coated balloons in the treatment of acute myocardial infarction (Review)

被引:11
作者
Hu, Huilin [1 ]
Shen, Liang [1 ]
机构
[1] Jiaxing Univ, Affiliated Hosp, Dept Cardiol, 1882 Zhonghuan South Rd, Jiaxing 314000, Zhejiang, Peoples R China
关键词
drug-coated balloons; percutaneous coronary intervention; acute myocardial infarction; PERCUTANEOUS CORONARY INTERVENTION; IN-STENT RESTENOSIS; MUSCLE-CELL-PROLIFERATION; BARE-METAL STENT; ELUTING STENT; ST-SEGMENT; ANGIOPLASTY; SIROLIMUS; MULTICENTER; TRIAL;
D O I
10.3892/etm.2021.9895
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Drug-eluting stents are the standard revascularization strategy for the treatment of symptomatic coronary artery disease. However, in-stent restenosis (ISR), stent thrombosis and reinfarction of target lesions following stent implantation present challenges. Drug-coated balloons (DCBs), which deliver antiproliferative drugs into the vessel wall without stent implantation, are a novel treatment option for percutaneous coronary intervention and have been proven to act as a promising strategy in the treatment of ISR and coronary small vessel disease. However, their role in acute myocardial infarction (AMI) remains unclear. The present review discusses current evidence for the treatment of AMI with DCBs.
引用
收藏
页数:6
相关论文
共 49 条
[1]  
Alawami M, 2019, NEW ZEAL MED J, V132, P34
[2]   Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon [J].
Ali, Rosli Mohd ;
Kader, Muhamad Ali S. K. Abdul ;
Ahmad, Wan Azman Wan ;
Ong, Tiong Kiam ;
Liew, Houng Bang ;
Omar, Al-Fazir ;
Zuhdi, Ahmad Syadi Mahmood ;
Nuruddin, Amin Ariff ;
Schnorr, Beatrix ;
Scheller, Bruno .
JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (06) :558-566
[3]   Drug-coated Balloons: Technologies and Clinical Applications [J].
Ang, Huiying ;
Lin, Jinjie ;
Huang, Ying Ying ;
Chong, Tze Tec ;
Cassese, Salvatore ;
Joner, Michael ;
Foin, Nicolas .
CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (04) :381-396
[4]  
Axel DI, 1997, CIRCULATION, V96, P636
[5]   First Results of the DEB-AMI (Drug Eluting Balloon in Acute ST-Segment Elevation Myocardial Infarction) Trial A Multicenter Randomized Comparison of Drug-Eluting Balloon Plus Bare-Metal Stent Versus Bare-Metal Stent Versus Drug-Eluting Stent in Primary Percutaneous Coronary Intervention With 6-Month Angiographic, Intravascular, Functional, and Clinical Outcomes [J].
Belkacemi, Anouar ;
Agostoni, Pierfrancesco ;
Nathoe, Hendrik M. ;
Voskuil, Michiel ;
Shao, ChunLai ;
Van Belle, Eric ;
Wildbergh, Thierry ;
Politi, Luigi ;
Doevendans, Pieter A. ;
Sangiorgi, Giuseppe M. ;
Stella, Pieter R. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (25) :2327-2337
[6]   Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig Lecture ESC 2014 [J].
Byrne, Robert A. ;
Joner, Michael ;
Kastrati, Adnan .
EUROPEAN HEART JOURNAL, 2015, 36 (47) :3320-+
[7]   Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography [J].
Cassese, Salvatore ;
Byrne, Robert A. ;
Tada, Tomohisa ;
Pinieck, Susanne ;
Joner, Michael ;
Ibrahim, Tareq ;
King, Lamin A. ;
Fusaro, Massimiliano ;
Laugwitz, Karl-Ludwig ;
Kastrati, Adnan .
HEART, 2014, 100 (02) :153-159
[8]   Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer? [J].
Chang M. ;
Park D.-W. .
Cardiology and Therapy, 2014, 3 (1-2) :1-12
[9]   An update on the clinical use of drug-coated balloons in percutaneous coronary interventions [J].
Cheng, Yanping ;
Leon, Martin B. ;
Granada, Juan F. .
EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (06) :859-872
[10]  
Claessen BE, 2010, CURR PHARM DESIGN, V16, P4012